Related Experiment Videos
Adverse effects of intravenous immunoglobulin therapy
M E Ryan1, M L Webster, J D Statler
1Department of Pediatrics, Geisinger Medical Center, Danville, Pennsylvania 17822-1339, USA.
Clinical Pediatrics
|January 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Penetrating neck trauma and the rising rates of deliberate self-harm: a single trauma centre experience.
Annals of the Royal College of Surgeons of England·2025
Risk factors for post-ERCP pancreatitis: a prospective, multicenter study.
Gastrointestinal endoscopy·2001
Biodistribution of radiolabeled [(3)H] CMT-3 in rats.
Current medicinal chemistry·2001
The lipophilicity, pharmacokinetics, and cellular uptake of different chemically-modified tetracyclines (CMTs).
Current medicinal chemistry·2001
Excessive matrix metalloproteinase activity in diabetes: inhibition by tetracycline analogues with zinc reactivity.
Current medicinal chemistry·2001
Giardia duodenalis Infection and Pachymeningitis in a Patient With Agammaglobulinemia.
Clinical pediatrics·2026
Successful Therapy of CNS Tuberculosis With Granulomatous Inflammation in Immunodeficiency.
Clinical pediatrics·2026
Evaluation of Alexithymia Level in Children With Cystic Fibrosis.
Clinical pediatrics·2026
Serological correlates of disseminated Borrelia burgdorferi infection in mouse models of tick challenge.
Microbiology spectrum·2026
IgG4-related disease - treatment with anti-CD20, anti-CD19 antibodies, and other new drugs.
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
[Advances in mechanical signal-regulated tumor immunity and its therapeutic development].
Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences·2026
Cytokine-independent activation of STAT5 promotes the persistence and function of CD4+ regulatory T cells.
Molecular therapy. Advances·2026
CAR design equips diverse immune cells with unique antigen-specific activation identities.
Molecular therapy. Oncology·2026